FDA grants breakthrough therapy designation to Lilly's lung cancer drug

Investing.comThursday, September 4, 2025 at 10:53:42 AM
FDA grants breakthrough therapy designation to Lilly's lung cancer drug
The FDA has granted breakthrough therapy designation to Lilly's new lung cancer drug, which could expedite its development and approval process.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Ready to build your own newsroom?

Subscribe to unlock a personalised feed, podcasts, newsletters, and notifications tailored to the topics you actually care about